Most Recent
The Fair Work Commission has rejected a former Australian Competition and Consumer Commission employee's unfair dismissal case, finding his argument that he resigned after the regulator repudiated his contract "disingenuous".
Trial in a five-year-old class action against Whitehaven Coal will proceed without further delay despite the plaintiff's late bid to tender an expert report, with a judge finding no extraordinary reason to push off the hearing date any longer.
Former Melbourne Demons chairman Glen Bartlett has been given the green light to relaunch a defamation case against the AFL club's president and other senior officials after discontinuing proceedings that were transferred from his home state of Western Australia to Victoria.
The crypto platform formerly known as Be Pay Australia has settled a trade mark infringement suit by BPay after court-ordered mediation, changing its name and paying $50,000 toward the legal costs of the bill payments giant.
Australian wine company McGuigan has lost its bid to trade mark 'Black Label' for its wine after Johnnie Walker, which makes the popular Black Label whiskey, successfully argued it would cause consumer confusion.
VCAT has found a Melbourne lawyer is not fit to practice after he sent threatening text messages to a witness in proceedings involving his former law firm.
A recent study has found that one-third of surveyed Australian judicial officers should be tested for PTSD, with alcohol ranking as a key coping strategy among stressed-out judges.
A GlaxoSmithKline unit has defeated Nova Pharmaceuticals' bid to trade mark 'Novadart' for a generic version of the British company's market-leading drug prostate drug 'Avodart', with a delegate finding the mark would cause consumer confusion.
An environmental group has argued a fracking project in the Northern Territory was approved before its risks were adequately scrutinized, taking advantage of changes in the law that allow "interested persons" to seek administrative review of government decisions.
US-based Dana-Farber Cancer Institute has succeeded in patenting a patient-specific method for developing cancer vaccines using genome sequencing.